In Vitro Evaluation of Levamisole Efficacy TowardGastrointestinal Worms of Domestic Chicken in Yogyakarta
DOI:
https://doi.org/10.29244/avi.13.2.%25pKeywords:
Key Words: Ascaridia galli, domestic chicken, levamisole, mortality time, Raillietina spp.Abstract
Levamisole is a broad-spectrum anthelmintic from the imidazothiazole derivative group for mammals and poultry. This study aims to evaluate the anthelmintic effectiveness of levamisole against gastrointestinal worms in domestic chickens in Yogyakarta. The findings of this study could potentially lead to the development of more effective strategies for controlling helminthiasis in poultry, thereby improving the health and productivity of domestic chickens. This study is an in vitro laboratory experiment that uses Ascaridia galli (AG) and Raillietina spp. (RL), in a petri dish with ten treatment groups (n=3). The groups consisted of two negative controls, 0.9% sodium chloride AG and RL (G1, G2), two groups of AG and RL in Carboxymethylcellulose Sodium (G3, G4), and levamisole treatment groups with doses of 0.02, 0.1, and 0.2% for three groups of AG (G5-G7) and three groups of RL (G8-G10), respectively. The worm’s mortality time was observed for 24 hours, while descriptive analyses were conducted between treatments with the scoring method. The 0.2% levamisole solution showed anthelmintic efficacy toward AG and RL of a domestic chicken, which in RL has the fastest time to die, 30 minutes of mortality time.
Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
All articles published Open Access will be immediately and permanently free for everyone to read and download. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA).